Skip to main content
Back to feed
MarketsSingle-sourceMedium
5.2

Pharmaceutical M&A activity surges 70% to 343.5 billion euros in H1 2026

Pharmaceutical deal volume reached 343.5 billion euros between January and July 2026, representing a 70% increase compared to the same period in the previous year. Major firms including Eli Lilly, Bristol Myers Squibb, AbbVie, and GSK are identified as the primary drivers of this consolidation trend.

Expansión3 days agoUS, GBCredibility 29%View source

Score Breakdown

Mosaic Score5.2
Confidence0.9
Significance0.5
Source credibility0.3

Intelligence Tags

#pharmaceuticals#m&a#healthcare#corporate-finance

Entities

countrycountry
Source

Related signals

8 found